Lewis Roberts, MB, ChB, PhD, and Jennifer Knox, MD, MSc, FRCPC announced as 2019 Conference Chairs.

SALT LAKE CITY, UT, USA, December 19, 2018 /EINPresswire.com/ -- The Cholangiocarcinoma Foundation (CCF) will host its 6th Annual Conference on January 30 to February 1, 2019 at the Salt Palace Convention Center in downtown Salt Lake City. This conference will be the largest single gathering of medical and research professionals, industry, policy makers, patients, caregivers and other global stakeholders with the sole focus of curing bile duct cancer. More than 40 sessions featuring internationally renowned speakers will present topics in basic, translational and clinical research from the bench-to-bedside perspective. Since the inaugural Conference in 2014, attendance has doubled each year. Based on this extraordinary success, we anticipate hosting more than 550 individuals from multiple countries.

CCF is pleased to announce Vivek Wadhwa, renowned author, entrepreneur, and academic as our keynote speaker. Mr. Wadhwa is a Distinguished Fellow and Adjunct Professor at Carnegie Mellon's School of Engineering at Silicon Valley, and Distinguished Fellow at the Labor and Worklife Program at Harvard Law School, and has published several books including; Your Happiness was Hacked: Why Tech is Winning the Battle to Control Your Brain - and How to Fight Back and Driver in the Driverless Car.

"Not long ago, rare cancers such as Cholangiocarcinoma were considered incurable. But thanks to the exponential advances in artificial intelligence, genomics, sensors, and synthetic biology the impossible is now becoming possible. We will make more progress over the next five years than we have made in the previous fifty; we will be able to cure almost any disease and live longer and healthier lives," stated Vivek.

The 2019 Conference Chairs are Lewis Roberts, MB, ChB, PhD, Gastroenterology and Hepatology Cancer Center, Mayo Clinic, Rochester, Minnesota, and Jennifer Knox, MD, MSc, FRCPC, Department of Medical Oncology of Princess Margaret Cancer Centre, Toronto, Canada, and Associate Professor of Medicine at the University of Toronto.

Conference sponsors to date include: Incyte, Debiopharm Group, EMD Serono, QED Therapeutics, Taiho Oncology, Agios, ASLAN Pharmaceuticals, Basilea Pharmaceutica, Mundipharma, Bayer Oncology, Bristol-Myers Squibb, Fujifilm, Leap Therapeutics, NuCana, PCI Biotech, Lexicon Pharmaceuticals, RedHill Biopharma, Zymeworks, Beigene and Sirtex. Industry Forum presenters to date include: Bayer Oncology, EMD Serono, QED Therapeutics, Debiopharm Group and FORMA Therapeutics.

Patients and caregivers—having experienced the disease firsthand—will be invited to learn about cholangiocarcinoma, share their personal experiences, and contribute to future efforts to further research. An Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI) will provide scholarships for 30 patients to attend and participate in all aspects of the Conference.

Programming will also include an Industry Forum, Poster Session, Patient Engagement Roundtables and Exhibit Hall.

Click here to register for the conference or view the agenda.

Jordan Giles
Cholangiocarcinoma Foundation
888-396-6731x10
email us here